|
| |
Overview
Financial Highlight
Headlines
Business Background Heitech Padu Bhd engages in the provision of systems integration, network related services, data center management, disaster recovery services and other information technology related services. The operating segments of the company are information technology mailing and document processing services engineering works. The company’s business activities include system application and development, trading of hardware and software and maintenance services. It also offers managed data center services, managed network and communications services, desktop management services, business continuity management, customer care and helpdesk services, and ICT deployment services. Most of the company’s revenue comes from Malaysia.
  chepac https://www.theedgemarkets.com/article/heitech-padu-inks-jv-agreement-construct-nextgen-data-centre-shah-alam 06/03/2021 7:20 PM RRWin89 As the price well cosolidated, depending on how the QR is, this counter will either boom or bust. 15/03/2021 9:06 PM  Khai Zam https://www.nst.com.my/news/nation/2021/04/680885/myimms-hacking-six-nabbed 09/04/2021 12:26 PM followKing hahaha......when wc start to promote then is no good sign for the counter :P 03/06/2021 11:31 AM winefficietly Top 30 shareholders holding app 71% shareholding in HT and with the balance float is approximately 29 mil shares floating is considered small float. With EPS of 10.83 sen and PE ratio of 13 which is low consider the industry the company i is technology. 17/06/2021 4:26 PM winefficietly Good potential for the company to grow further as major clients are reputable parties Regal Orion Sdn Bhd which considered big player in big data and will allowed company to generate good stream of income from the agreement enter into 17/06/2021 4:32 PM winefficietly With Wong TS who recently emerges as shareholder of widetech approximately 12.3% and his holding in HT Padu which he will not be acting passively in his investment, hence can see HT Padu have a good prospect with S5 also in the cards for the group to reliase 17/06/2021 4:41 PM  Mr.Sm Invest123 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS MY E.G. Services Berhad ("MYEG" or "the Company") - Joint Venture Agreements entered between:- (1) Shigatse Service Co., Ltd. and MYEG Medical Services Sdn. Bhd., a wholly-owned sub-subsidiary of the Company; and (2) SinoPhil Biotech Inc., Shigatse Service Co., Ltd. and I-PAY MYEG Philippines Inc., a joint venture company of the Company. MY E.G. SERVICES BERHAD Type Announcement Subject TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS Description MY E.G. Services Berhad ("MYEG" or "the Company") - Joint Venture Agreements entered between:- (1) Shigatse Service Co., Ltd. and MYEG Medical Services Sdn. Bhd., a wholly-owned sub-subsidiary of the Company; and (2) SinoPhil Biotech Inc., Shigatse Service Co., Ltd. and I-PAY MYEG Philippines Inc., a joint venture company of the Company. The Board of Directors of the Company wishes to announce that MYEG Medical Services Sdn. Bhd., a wholly-owned sub-subsidiary of the Company and I-Pay MYEG Philippines Inc., a joint venture company of the Company, had on 17 June 2021 entered into joint venture agreements respectively in their respective territories. Please refer to the attachment for further details. This announcement is dated 17 June 2021. 17/06/2021 8:24 PM Mr.Sm Invest123 KUALA LUMPUR (Bernama) -- My E.G. Services Bhd has signed a letter of intent (LOI) to purchase 10 million doses of Anhui Zhifei Biopharmaceutical Co Ltd’s COVID-19 vaccine, ensuring that the corresponding quantity of its recombinant protein subunit vaccine is reserved for delivery as early as August. In a filing with Bursa Malaysia, MYEG said it holds three-year rights to exclusively distribute the vaccine in Malaysia while through a separate partnership, the group has two-year exclusive distribution rights to the vaccine in the Philippines and is presently in discussions to distribute in other countries. "Last week, MYEG announced plans for the roll-out of a vaccination programme in the Philippines that will cover the provision of the vaccines to the public health segment as well as private sales,” it said. The LOI is to ensure that the corresponding quantity of Zhifei’s recombinant protein subunit vaccine is reserved for delivery as early as August when vaccination through the private market is enabled. "This paves the way for the vaccine to be imported and made available to Malaysians as soon as the private market commences and subject to the conditional authorisation of the vaccine by the National Pharmaceutical Regulatory Agency (NPRA),” it said. The cost of the vaccine will be determined later subject to the conditional authorisation by NPRA. MYEG said it is confident that when the Zhifei vaccine becomes available locally, it can play an important role in accelerating the country’s drive towards achieving herd immunity against the COVID-19 virus. Jointly developed by Zhifei and the Institute of Microbiology of the Chinese Academy of Sciences, the vaccine has fast emerged as among the preferred vaccines in China since gaining emergency use authorisation there in early March in view of its distinct inherent advantages as a recombinant protein subunit vaccine. More than 60 million doses have already been administered in more than a dozen provincial-level regions, including Beijing. The vaccine is also being used in Uzbekistan. Recombinant protein technology is proven, having been used for the development of vaccines such as hepatitis B and shingles. In addition, recombinant protein vaccines can be more easily produced at a large-scale since production does not need to be carried out in high-grade biosafety laboratories, and they are also more cost-effective and easier to store and transport. Since the outbreak of the COVID-19 virus, MYEG has leveraged its strengths and expertise as a leading digital services provider in the region to introduce a number of significant initiatives as part of a holistic solution aimed at helping in the fight against the pandemic. Besides vaccines, these offerings include screening services, quarantine management and digital health travel pass systems. 26/06/2021 12:58 AM winefficietly With indicators shown oversold position at 10 (Stochastic) and RSI of only 41, this likely a good counter to look into. Furthermore coming quarter result will likely look impressive 02/07/2021 3:21 PM michaelwong Something is brewing and likely to ceiling up with strong buying support 05/07/2021 11:38 AM punterking Always 1 day show. Few million shares transacted yesterday PUC slightly more than 101M. Who sells & who buys???? 06/07/2021 12:46 PM ahwong95 this is called consolidation. one day it will fly and never go back to this price..just like sedania will never go back to 20sen 10/07/2021 2:51 PM halimboss no more business for this company. too many leakages and dead riders inside. 11/07/2021 7:44 PM shlyw Politic Concept Counter / 政治概念股 1️⃣ Muhyiddin 概念股 - EDEN 7471 - THRIVEN 7889 2️⃣ Anwar 概念股 - MUIPROP 3913 - PMCORP 4081 - ASB 1481 - MUIIND 3891 3️⃣ Mahathir 概念股 - OPCOM 0035 - PETRONM 3042 4️⃣ Najib 概念股 - GKENT 3204 - JOHAN 3441 - ANCOM 4758 5️⃣ MCA 概念股 - MATANG 0189 - STAR 6084 6️⃣ UMNO 概念股 - KUB 6874 - MEDIA 4502 - UEMS 5148 7️⃣ 政府关联概念股 - FGV 5222 - MYEG 0138 - DNEX 4456 - MRCB 1651 - SASBADI 5252 - DSONIC 5216 - HTPADU 5028 - DESTINI 7212 8️⃣ SABRI 沙比里的概念股 -AVI 8885 -AIM 0122 -UCREST 0005 22/08/2021 12:24 PM  Keyman188 Aiyo...game sudah over lorrr... PM nomination sudah confirmed lorrr... No related political counters lorrr... Masih nak mimpi ge... wkwkwk...kekeke...hehehe... 22/08/2021 5:26 PM  TheAlphaTrader https://klse.i3investor.com/blogs/thealphatrader/2022-01-17-story-h1597411394-HEITECH_PADU_BHD_5028_ENTERING_THE_DATA_CENTRE_BUSINESS_IN_A_BIG_WAY.jsp 17/01/2022 3:21 PM sherlockman https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3226854 18/01/2022 8:33 PM chcheah another dead share in the making. very bad results. no wonder even the placement called off. going to become a useless penny stock soon. 28/02/2022 6:05 PM  | |
